[A multi-center clinical trial of Qianlieantong tablets for chronic prostatitis].
OBJECTIVE
To observe the efficacy and safety of Qianlieantong Tablets in the treatment of chronic prostatitis.


METHODS
A multi-center, self-controlled open clinical trial was conducted. A total of 280 subjects with chronic prostatitis were enrolled and treated by Qianlieantong Tablets, 3 times a day, 5 tablets each time. Before and after 2 and 4 weeks after the administration, NIH-CPSI scores and white blood cell counts in the prostate secretion were recorded.


RESULTS
Of the 273 subjects evaluated, the rates of excellence, effectiveness and ineffectiveness were 35.2% (n = 96), 47.6% (n = 130) and 17.2% (n = 47), respectively, with a total effectiveness rate of 82.8%. After 4 weeks'medication, the scores of the subjects on NIH-CPSI pain, voiding and quality of life and white blood cell counts in prostate secretion were significantly decreased compared with pre-treatment (P < 0.01). No adverse events or laboratory abnormality related to the medication were observed.


CONCLUSIONS
Qianlieantong Tablets has a significant effect on chronic prostatitis with high safety, particularly indicated in chronic prostatitis with pelvic pain.
Guo
Kai
K
Department of Urology, Peopleś Hospital of Sichuan Province, Chengdu, Sichuan 610072, China. yiqiao@163.com
Qiu
Ming-Xing
MX
Cai
Song-Liang
SL
Leng
Jing
J
Han
Yin-Fa
YF
Shao
Guo-Xing
GX
Wang
Chuan-Hang
CH
Tu
Xiang-An
XA
Yang
Luo-Yan
LY
Chen
Ge-Ming
GM
Zhou
Qiang
Q
Deng
Yong
Y
Wang
Xiao-Long
XL
D000328:Adult; D002908:Chronic Disease; D004334:Drug Administration Schedule; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008516:Medicine, Chinese Traditional; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy*; D011788:Quality of Life; D013607:Tablets; D016896:Treatment Outcome
D004365:Drugs, Chinese Herbal; D013607:Tablets; C532631:qianlieantong